Atsumi T - Search Results

1

Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.

Ninagawa K, Kato M, Nakamura H, Abe N, Kono M, Fujieda Y, Oku K, Yasuda S, Ohira H, Tsujino I, Atsumi T. Ninagawa K, et al. Among authors: atsumi t. Rheumatol Int. 2019 Nov;39(11):1883-1887. doi: 10.1007/s00296-019-04370-0. Epub 2019 Jul 6. Rheumatol Int. 2019. PMID: 31280357 Free article.

2

Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies.

Yasuda S, Tsutsumi A, Atsumi T, Bertolaccini ML, Ichikawa K, Khamashta MA, Hughes GR, Koike T. Yasuda S, et al. Among authors: atsumi t. J Rheumatol. 2002 Jun;29(6):1192-7. J Rheumatol. 2002. PMID: 12064834

3

Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis.

Yasuda S, Atsumi T, Ieko M, Matsuura E, Kobayashi K, Inagaki J, Kato H, Tanaka H, Yamakado M, Akino M, Saitou H, Amasaki Y, Jodo S, Amengual O, Koike T. Yasuda S, et al. Among authors: atsumi t. Blood. 2004 May 15;103(10):3766-72. doi: 10.1182/blood-2003-08-2712. Epub 2004 Jan 15. Blood. 2004. PMID: 14726399 Free article.

4

The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies.

Bohgaki M, Atsumi T, Yamashita Y, Yasuda S, Sakai Y, Furusaki A, Bohgaki T, Amengual O, Amasaki Y, Koike T. Bohgaki M, et al. Among authors: atsumi t. Int Immunol. 2004 Nov;16(11):1633-41. doi: 10.1093/intimm/dxh166. Epub 2004 Oct 5. Int Immunol. 2004. PMID: 15466912

5

Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.

Yasuda S, Atsumi T, Ieko M, Koike T. Yasuda S, et al. Among authors: atsumi t. Thromb Res. 2004;114(5-6):461-5. doi: 10.1016/j.thromres.2004.07.013. Thromb Res. 2004. PMID: 15507279 Review.

6

Antiprothrombin antibodies--are they worth assaying?

Atsumi T, Amengual O, Yasuda S, Koike T. Atsumi T, et al. Thromb Res. 2004;114(5-6):533-8. doi: 10.1016/j.thromres.2004.08.024. Thromb Res. 2004. PMID: 15507288 Review.

7

Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.

Yasuda S, Atsumi T, Matsuura E, Kaihara K, Yamamoto D, Ichikawa K, Koike T. Yasuda S, et al. Among authors: atsumi t. Arthritis Rheum. 2005 Jan;52(1):212-8. doi: 10.1002/art.20741. Arthritis Rheum. 2005. PMID: 15641049 Free article.

8

Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich element.

Fukae J, Amasaki Y, Yamashita Y, Bohgaki T, Yasuda S, Jodo S, Atsumi T, Koike T. Fukae J, et al. Among authors: atsumi t. Arthritis Rheum. 2005 Sep;52(9):2697-707. doi: 10.1002/art.21258. Arthritis Rheum. 2005. PMID: 16142751 Free article.

9

Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies.

Kasahara H, Matsuura E, Kaihara K, Yamamoto D, Kobayashi K, Inagaki J, Ichikawa K, Tsutsumi A, Yasuda S, Atsumi T, Yasuda T, Koike T. Kasahara H, et al. Among authors: atsumi t. Int Immunol. 2005 Dec;17(12):1533-42. doi: 10.1093/intimm/dxh330. Epub 2005 Oct 12. Int Immunol. 2005. PMID: 16221723

10

Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.

Atsumi T, Amengual O, Yasuda S, Matsuura E, Koike T. Atsumi T, et al. Autoimmunity. 2005 Aug;38(5):377-81. doi: 10.1080/08916930500124312. Autoimmunity. 2005. PMID: 16227153 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,061 results

Search Page

Filters